Hopp til hovedinnhold

Behçet´s sykdom - Nevrobehçet

Sist oppdatert: Sist revidert:
Sist revidert av:


UptoDate, BMJ BestPractice

  1. Kidd DP. Neurological complications of Behçet's syndrome. J Neurol. 2017 Mar 10 . pmid:28283819 PubMed  
  2. Tsalta-Mladenov ME, Georgieva DK, Andonova SP. Neuro-Behcet´s disease - case report and review. Acta Reumatol Port. 2020 Apr-Jun;45(2):137-142. English. PMID: 32898126. PubMed  
  3. Borhani-Haghighi A, Kardeh B, Banerjee S, Yadollahikhales G, Safari A, Sahraian MA, Shapiro L. Neuro-Behcet's disease: An update on diagnosis, differential diagnoses, and treatment. Mult Scler Relat Disord. 2019 Dec 23;39:101906. PMID: 31887565. PubMed  
  4. Peño IC, De las Heras Revilla V, Carbonell BP, Di Capua Sacoto D, Ferrer ME, García-Cobos R, González RA.. Neurobehçet disease: clinical and demographic characteristics.. Eur J Neurol. 2012 ; 19: 1224-7. pmid:22469257 PubMed  
  5. Akdal G, Toydemir HE, Saatci AO, Uygunoğlu U, Altunrende B, Saip S, Yaman A, Keskinoğlu P, Yilmaz SG, Çelebisoy N, Bajin MS, Siva A, Akman-Demir G. Characteristics of optic neuropathy in Behçet disease. Neurol Neuroimmunol Neuroinflamm. 2018 Aug 10;5(5):e490. PMID: 30175164 PubMed  
  6. Desbois AC, Addimanda O, Bertrand A, Deroux A, Pérard L, Depaz R, Hachulla E, Lambert M, Launay D, Subran B, Ackerman F, Mariette X, Cohen F, Marie I, Salvarini C, Cacoub P, Saadoun D. Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study. Medicine (Baltimore). 2016 Jun;95(23):e3550 . pmid:27281066 PubMed  
  7. Karabulut Y. Use of non-TNF biologics for the treatment of neuro-Behçet's disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab. Eur J Rheumatol. 2021 Sep 16. doi: 10.5152/eurjrheum.2021.20160. Epub ahead of print. PMID: 34554909. PubMed  
  8. Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H. 2018 update of the EULAR recommendations for the management of Behçet's syndrome. Ann Rheum Dis. 2018 Jun;77(6):808-818. PMID: 29625968. PubMed  
  9. Sahin Eroglu D, Torgutalp M, Yucesan C, Sezer S, Yayla ME, Boyvat A, Ates A. Prognostic factors for relapse and poor outcome in neuro-Behçet's syndrome: results from a clinical long-term follow-up of a single centre. J Neurol. 2022 Apr;269(4):2046-2054. doi: 10.1007/s00415-021-10787-0. Epub 2021 Sep 4. PMID: 34482435. PubMed  
  10. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990; 335: 1078-80. pmid:1970380 PubMed  
  • Unn Ljøstad, spesialist i nevrologi, professor, PhD
  • Åse Mygland, spesialist i nevrologi, professor, dr med